L Catterton, the consumer-focused investment firm that bought SignatureMD, also became a co-lead investor in US Fertility. Its investments connect concierge medicine and fertility care through an owner with experience in branding and consumer demand. For a physician, the practical question is what that experience brings to the office, and what authority the network receives in return.
Provident Healthcare Partners reported L Catterton's acquisition of SignatureMD from Blue Sea Capital among transactions completed in the first quarter of 2026. Its report described a network supporting more than 250 physicians across 35 states.[1]
The fertility investment came earlier. US Fertility announced its partnership with L Catterton and existing investor Amulet Capital on November 25, 2025. At that time, the company reported more than 200 physicians across 121 in vitro fertilization (IVF) clinic and laboratory locations.[2]
Both businesses depend in part on patients choosing a provider and making a personal financial commitment.
What the Fertility Deal Actually Says
September coverage in Becker's ASC Review reported that L Catterton and Amulet each held 42.5% of US Fertility, with physicians and management holding the remaining 15%.[3] The company's announcement confirms the two firms became co-lead investors and physician partners retained equity, but does not publish those percentages.[2]
Trade coverage also described up to $1.7 billion in capital associated with the transaction.[3] That figure does not establish L Catterton's individual investment.
There is a separate, directly documented financing figure. KeyBanc reported arranging $1.07 billion in senior secured credit facilities in December 2025: an $825 million term loan, a $120 million revolving facility, and a $125 million delayed-draw term loan. Its account says proceeds supported a recapitalization involving new L Catterton equity and the acquisition of Genetics & IVF Institute.[4]
Those facilities describe borrowing arrangements. They are distinct from investors' equity contributions and the company's valuation. The available primary sources did not provide a breakdown reconciling the reported $1.7 billion, so we cannot use it to calculate L Catterton's equity check or what US Fertility was worth.
The timing also matters. Fertility Bridge reported the ownership split and $1.7 billion figure in December 2025.[5] September's coverage brought renewed attention to an existing transaction.
The ownership connection is established. The operating implications require a closer look at what each company does for its affiliated physicians.
Founders and Origins: What Each Business Was Built to Do
Matthew Jacobson founded SignatureMD in 2006. Blue Sea Capital's 2019 investment announcement described a business helping physicians convert to concierge medicine and providing ongoing support afterward. Jacobson was founder and CEO at the time and retained an ownership stake in that transaction.[6]
That history matters because patient recruitment and membership operations were already part of SignatureMD's business. Blue Sea itself described the opportunity in terms of consumer-driven healthcare in 2019.[6] L Catterton acquired an existing approach to supporting practices.
US Fertility formed in 2020 through Amulet Capital and Shady Grove Fertility, with Mark Segal as its founding CEO. Its launch announcement described a business-support organization providing resources to fertility practices.[7]
L Catterton took its current form in 2016, combining Catterton with private equity and real estate investment operations associated with luxury group LVMH and Groupe Arnault. The firm describes its LVMH relationship as a source of consumer, brand, and retail expertise.[8]
The businesses still have different economics. SignatureMD supports a recurring membership relationship, making renewals an important measure for an affiliated practice. Fertility care centers on a course of treatment and may include laboratory services. A useful marketing or pricing approach in one setting needs to be evaluated on its own terms in the other.
Our earlier report on SignatureMD's sale to L Catterton covers the acquisition. Here, the focus is what physicians receive from the network and how to evaluate that support.
What Consumer Expertise Could Add
L Catterton's investment announcement emphasized understanding consumers and improving the fertility patient experience.[2] For a physician, that becomes useful only when it produces something specific.
A practice might benefit from a clearer explanation of its membership, more reliable responses to inquiries, or better information about why prospective patients decide against joining. A network might also test marketing approaches across several offices and help physicians avoid spending money on channels that produce inquiries but few appropriate enrollments.
Those are potential benefits to evaluate, not changes we have verified at SignatureMD following the acquisition.
SignatureMD's physician FAQ already advertises marketing and sales support, conversion assistance, and ongoing practice support.[9] An existing affiliate should compare any new proposal with the services already included in its arrangement. More investment creates value for that physician only if it improves the service or its economics.
For example, a proposed program might promise more patient inquiries. Follow those inquiries through to completed enrollments and subsequent renewals. Establish who responds, how quickly, and which parts of the campaign the physician can adjust when local results differ from the network's expectations.
Our coverage of private equity's growth in concierge medicine provides the wider ownership context. An individual practice still needs evidence that the proposed support works for its patients and economics.
Start by Separating Network Ownership From Practice Ownership
A sale of SignatureMD does not, by itself, show that every affiliated physician sold a practice to L Catterton.
SignatureMD publicly presents its model as supporting independent practices.[10] Physicians should identify the arrangement they actually have: a services agreement, an affiliation, an employment relationship, or an ownership transaction. Those arrangements can allocate responsibilities very differently.
The distinction also matters to patients. Our guide to what happens when a concierge doctor retires, sells, or joins a network explains why a familiar name over the door does not answer every continuity question.
Start with the signed documents and any proposed amendments. Identify who owns the medical practice, who provides support services, and which entity receives membership payments. Have your advisers explain provisions that address transferring the agreement or changing the support company's ownership.
The public acquisition reports do not disclose individual physicians' agreements. They cannot establish that a particular doctor's fee, staffing authority, or clinical control changed.
Four Decisions Worth Examining
1. Who Sets the Membership Price?
A consumer investor may bring experience studying what customers value and how they respond to pricing. A physician needs to understand who can act on that analysis.
Ask who proposes a fee change, who approves it, how existing members are treated, and how much notice patients receive. Model the practice's revenue after the network's charges and the staff costs needed to deliver the promised service.
Consider a hypothetical practice with 300 members paying $2,000 a year: annual membership revenue is $600,000. If the fee rises to $2,200 and membership falls to 275, revenue reaches $605,000. A 10% fee increase produces less than 1% more gross revenue in this example, before network charges or practice expenses. Compare that result with patient access, workload, and the reasons members leave.
We found no verified announcement of a SignatureMD-wide fee increase tied to this acquisition. The question belongs in a contract review because pricing authority matters, regardless of whether anyone currently plans to use it.
2. What Does the Marketing Promise Require of the Office?
Every promise about access becomes work for someone. If a campaign advertises easier communication or more help between visits, the practice needs staffing and coverage to deliver it.
Ask who approves patient-facing claims and who handles a mismatch between a national campaign and a local office's capabilities. Track complaints about the service patients expected when they enrolled, alongside enrollment and renewal figures.
A useful marketing program should help suitable patients understand the practice. A physician should be able to explain the service in the same terms after the patient joins.
3. Which Services Become Centralized?
US Fertility describes support spanning functions such as purchasing, technology, human resources, and marketing. It also states that healthcare decisions remain with individual practices.[11]
Those are US Fertility's stated services and commitments. A SignatureMD affiliate needs to examine its own agreement.
For your own office, examine each proposed central service separately. A shared vendor may reduce a bill. A centralized team may take work off local staff. Ask who resolves mistakes, what response time is promised, and what happens when the service does not meet the practice's needs.
Measure hours returned to patient care and unresolved work as well as expenses. A lower vendor price provides limited value if the physician must spend more time fixing the resulting problems.
4. What Control and Flexibility Does the Physician Retain?
Ask how decisions about staffing, scheduling, clinical services, and practice identity are made. Establish whether a new business program is optional and what obligations come with participating.
If a proposal includes an ownership stake, examine its terms separately from compensation for medical work. Establish when it could be sold, what restrictions apply, and what happens when a physician retires or leaves. A percentage of ownership alone does not describe those rights.
These are questions for the specific agreement. Public statements about physician autonomy provide context, but the documents governing your relationship need to support the commitments you are relying on.
The Comparison Has Limits
Calling both businesses “self-pay healthcare” misses important differences. SignatureMD's FAQ says members continue using insurance or Medicare for covered medical care.[9] US Fertility includes managed-care services among its support functions.[11] Neither fact supports treating every dollar of revenue as a direct consumer payment.
There is also a healthcare specialist in the fertility deal. Amulet remained a co-lead investor and increased its investment.[2] The transaction combines consumer and healthcare investing experience. It does not show one replacing the other.
That matters when interpreting the buyer's identity. Both kinds of investor can care about growth, staffing efficiency, and patient acquisition. What distinguishes a particular arrangement is how those objectives are translated into obligations, incentives, and operating authority.
Request a First-Year Operating Plan
Before joining a network or accepting a new program, request a plan that connects each promised benefit to an accountable person, a cost, and a measure of performance.
For patient recruitment, track inquiries, enrollments, and the cost of acquiring each member. For practice support, identify the tasks the network takes over and how unresolved requests are handled. For membership changes, document who approves the fee, service commitments, and patient communications.
An existing affiliate can compare that plan with the prior year's experience. A physician considering affiliation can use the same questions to compare offers. Review the service delivered after enrollment as closely as the sales presentation before it.
L Catterton's fertility investment makes its interest in consumer healthcare clearer. Whether that creates value for a concierge physician will depend on what the network delivers to the practice and what the physician agrees to in return.
FAQ
Did L Catterton invest $1.7 billion by itself in US Fertility?
The sources reviewed do not establish that. Trade coverage reports up to $1.7 billion associated with the transaction; KeyBanc separately documents $1.07 billion in credit facilities.[3][4] Neither establishes L Catterton's individual equity check.
Is this a new September 2026 acquisition?
No. US Fertility announced the partnership in November 2025. Provident reported the SignatureMD acquisition among completed first-quarter 2026 transactions.[1][2]
Does L Catterton own every SignatureMD physician's practice?
A network acquisition does not establish that. SignatureMD describes support for independent practices; each physician's ownership and contractual arrangement needs to be examined separately.[10]
Does the fertility deal prove SignatureMD will change its prices or clinical policies?
No. We found no verified announcement establishing those changes. Physicians can use the transaction as a reason to review operating commitments and decision rights without assuming a particular change has occurred.
Physicians can review how patients encounter their practice and its membership information in NextMD's concierge and direct primary care directory.
Sources
Provident Healthcare Partners. (2026, April). Q1 2026 Healthcare M&A Update, primary care transaction coverage. Read the full quarterly report.
US Fertility. (2025, November 25). US Fertility Forms Strategic Partnership to Accelerate Growth and Expand Access to Advanced Reproductive Care. Read the company announcement.
Newitt, Patsy. (2026, September 3). The firm behind Peloton is betting on physician practices next. Becker's ASC Review. Read the ownership and financing coverage.
KeyBanc Capital Markets. (Transaction closed December 2025). US Fertility completes debt refinancing. Read the lender's financing breakdown.
Shinkman, Ron. (2025, December 11). L Catterton Buys 42.5% Stake in US Fertility. USF Expected to Do Almost $1B in 2026. Inside Reproductive Health / Fertility Bridge. Read the earlier transaction coverage.
Blue Sea Capital. (2019, April 1). Blue Sea Capital Invests in Leading Provider of Concierge Healthcare Support Services. Read SignatureMD's founder and investment history.
US Fertility. (2020, May 21). Amulet Capital and Shady Grove Fertility Form US Fertility. Read the formation announcement.
L Catterton. (Accessed September 9, 2026). LVMH Relationship. Read the firm's formation and consumer-business background.
SignatureMD. (Accessed September 9, 2026). Frequently Asked Questions for Physicians. Read the practice-support and insurance description.
SignatureMD. (Accessed September 9, 2026). About Us. Read the company's description of independent-practice support.
US Fertility. (Accessed September 9, 2026). Practice Management. Read its support services and practice-autonomy description.